Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

Thumbnail

CT imaging features forecast outlook for patients with aggressive pancreatic cancer

Radiologists combined 10 key radiomic features with other clinical information to predict which patients were expected to survive more than three years.

Thumbnail

NIH doles out $11.2M for new super-resolution genome imaging center

The goal is to visualize the entire human genome, which could have important implications for understanding genetic diseases, chromosomes and more.

Pediatric patients engaged in VR much less troubled by pain

Virtual reality was highly effective at distracting young patients experiencing physical pain in a recent randomized trial. 

Thumbnail

Digital pathology lab deploys ‘world’s 1st’ AI-powered solution for gastrointestinal cancers

Tel Aviv, Israel-based Ibex Medical Analytics earned FDA Breakthrough Device Designation status for its platform recently after publishing promising results in The Lancet Digital Health.

Thumbnail

Startup aiming to root out misdiagnoses in radiology raises $25M in new funding

New York-based Covera Health said the Series C financing comes by way of private equity firm Insight Partners, with additional contributions from existing investors. 

Thumbnail

New AI model predicts heart failure hospitalizations

Detecting heart failure issues early on, one researcher observed, can improve patient care and hospital efficiency at the same time. 

Treatable tumor models grown in the lab

The bioprinted replicas can preview a given tumor’s reaction to specific therapies and combinations thereof.

Nanox

Nanox sees stock slide after FDA finds deficiencies in application for novel imaging system

The Israel-based radiology startup said it plans to respond by the 180-day deadline, but did not indicate whether the rollout of its technology will be postponed.